![]() |
市场调查报告书
商品编码
1957300
实验室及人体组织市场-全球产业规模、份额、趋势、机会、预测:按产品、应用、最终用户、地区及竞争对手划分,2021-2031年Laboratory Robotics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球劳动机器人市场预计将从 2025 年的 31 亿美元成长到 2031 年的 48.4 亿美元,复合年增长率为 7.71%。
此领域涵盖用于临床诊断和生命科学研究中执行重复性功能的机械和自动化系统,例如液体分装、样品处理和微孔板操作。主要成长要素包括药物研发中对高通量筛检日益增长的需求,以及减少复杂分析过程中人为错误的必要性。此外,熟练技术人员的长期短缺也加速了这些技术的应用,以确保操作的一致性和效率。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 31亿美元 |
| 市场规模:2031年 | 48.4亿美元 |
| 复合年增长率:2026-2031年 | 7.71% |
| 成长最快的细分市场 | 自动化液体处理机器人 |
| 最大的市场 | 北美洲 |
儘管存在这些优势,但由于初始部署需要大量资金以及将这些系统整合到现有基础设施中存在许多困难,市场仍面临重大挑战。根据国际机器人联合会的数据,该产业正经历着向自动化方向的重大转变,预计到2024年,医疗检测和诊断机器人的销售将激增610%。虽然这一成长凸显了该领域自动化的迫切性,但小型机构的采用仍然受到资金和技术限制的阻碍。
透过流程自动化解决技术纯熟劳工短缺问题的迫切性是检查室机器人市场的主要驱动力。慢性病发病率的上升导致检测数量不断增加,造成工作量与人力供应之间存在巨大缺口。人才难寻和人员流动率高加剧了这个问题。自动化透过处理劳动密集和重复性任务来减轻这一负担,使有限的人员能够专注于复杂的分析,并有助于防止职业倦怠。根据美国临床病理学会于2025年10月发布的《2024年职缺调查》,病理科的职缺率高达28.5%,凸显了严重的员工短缺问题,因此需要采用机器人解决方案来维持检测量。
同时,对高通量检测成本效益和扩充性的追求正推动该领域的大规模投资。临床实验室和生命科学公司正在采用自动化系统来提升其研发和生产能力,同时又不增加营运成本。在许多情况下,这是透过对传统工作流程进行现代化改造以满足全球医疗保健需求来实现的。例如,赛默飞世尔科技公司于2025年4月宣布了一项计划,将在四年内投资20亿美元,以加强其在美国的製造和检测服务部门。国际机器人联合会(IFR)发布的《2025年报告》也印证了这一行业趋势,该报告指出,医疗机器人的销量在上年度增长了91%,达到约16700台。
全球劳动机器人市场面临的主要障碍之一是实施所需的巨额前期资本投入。部署机械臂和流体处理平台等先进自动化系统所需的资金往往超出学术Start-Ups、独立临床检查室和小规模研究机构的预算。这种经济差距造成了市场两极化,只有资金雄厚的製药公司才能充分利用自动化技术,迫使小规模的机构依赖人工流程。此外,将这些复杂的设备整合到现有基础设施中成本高昂,且需要专业技术,进一步加剧了挑战。
这些财务障碍的严重性体现在越来越多采用替代资金筹措模式以减少资本支出。 2024年,国际机器人联合会报告称,全球采用机器人即服务(RaaS)合约运作的专业服务机器人部署量成长了31%。这种基于订阅和租赁的部署方式的增长表明,预算限制正在阻碍自动化市场相当一部分企业的资本支出。简而言之,儘管对效率的营运需求仍然强劲,但传统的采购模式仍然阻碍着资金受限的产业领域更广泛地采用自动化技术。
透过将人工智慧整合到预测性工作流程中,实验室操作正从被动执行转变为主动优化。除了自动化诸如微孔板转移和液体处理等重复性任务外,先进的演算法还能即时评估实验参数、预测设备故障、识别数据异常,并在工作流程完成前优化检测方案。这种向数据驱动的智慧生态系统的转变,使实验室能够减少昂贵试剂的浪费,并缩短发现的时间。根据皮斯托亚联盟于2024年9月发布的《2024年未来实验室全球调查》,目前有68%的生命科学专业人员正在使用人工智慧和机器学习,这一比例较上年显着增长,显示实验室越来越重视资料准备工作。
同时,自动化解决方案在次世代定序和基因组学领域的拓展,正显着刺激实验室市场,以满足精准医疗的复杂需求。要实现这些精细基因组工作流程的自动化,需要高精度机器人来处理微量昂贵的生物样本,并防止交叉污染——这是传统工业自动化无法满足的要求。这导致对专用生物医学机器人系统的订单激增,美国自动化协会(Association for Advancing Automation)在2025年2月发布的报告中也强调了这一趋势。报告显示,2024年製药、生命科学和生物医学领域的机器人订单成长了46%,超过了传统工业领域的成长速度。
The Global Laboratory Robotics Market is projected to expand from USD 3.10 Billion in 2025 to USD 4.84 Billion by 2031, registering a CAGR of 7.71%. This sector comprises mechanical devices and automated systems utilized in clinical diagnostics and life science research to execute repetitive functions like liquid dispensing, sample handling, and plate manipulation. Key growth drivers include the rising demand for high-throughput screening in drug discovery and the imperative to reduce human error in intricate analytical processes, while a persistent shortage of skilled technicians further accelerates the adoption of these technologies to ensure operational consistency and efficiency.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.10 Billion |
| Market Size 2031 | USD 4.84 Billion |
| CAGR 2026-2031 | 7.71% |
| Fastest Growing Segment | Automated Liquid Handling Robots |
| Largest Market | North America |
Despite these advantages, the market faces significant hurdles due to the substantial capital required for initial implementation and the difficulties associated with integrating these systems into existing infrastructure. Data from the International Federation of Robotics indicates a massive industry pivot toward automation, noting that sales of robots for medical laboratory analysis and diagnostics surged by 610 percent in 2024. While this increase underscores the sector's urgency to automate, financial and technical constraints continue to hinder adoption among smaller institutions.
Market Driver
The urgent need to address skilled labor deficits through process automation acts as a major catalyst for the laboratory robotics market. Rising chronic disease prevalence has increased testing volumes, creating a significant disparity between workload requirements and the available workforce, a problem worsened by recruitment struggles and high retirement rates. Automation alleviates this pressure by handling labor-intensive, repetitive tasks, enabling limited personnel to concentrate on complex analysis and mitigating burnout. According to the American Society for Clinical Pathology's '2024 Vacancy Survey', released in October 2025, anatomic pathology departments experienced a substantial vacancy rate of 28.5%, highlighting the critical staffing shortages that demand robotic solutions to sustain throughput.
Simultaneously, the drive for cost efficiency and operational scalability in mass testing is fueling significant investment in the sector. Clinical laboratories and life science firms are deploying automated systems to bolster research, development, and manufacturing capacities without a corresponding rise in operational expenses, often by modernizing legacy workflows to meet global healthcare demands. For instance, Thermo Fisher Scientific announced in April 2025 a commitment to invest $2 billion over four years to upgrade its U.S. manufacturing and lab services. This industry-wide trend is further corroborated by the International Federation of Robotics, which reported in 2025 that sales of medical robots rose by 91% to roughly 16,700 units during the previous year.
Market Challenge
A major obstacle impeding the Global Laboratory Robotics Market is the substantial upfront capital investment necessary for implementation. Acquiring advanced automated systems, such as robotic arms and liquid handling platforms, requires significant financial outlay that frequently surpasses the budgets of academic startups, independent clinical labs, and smaller research institutions. This economic disparity results in a polarized market where only well-funded pharmaceutical companies can fully utilize automation, compelling smaller organizations to depend on manual processes, a challenge further complicated by the costs and technical expertise needed to integrate these complex units into legacy infrastructure.
The severity of this financial barrier is reflected in the increasing adoption of alternative financing models designed to reduce capital expenditure. In 2024, the International Federation of Robotics reported a 31% increase in the global fleet of professional service robots functioning under Robot-as-a-Service (RaaS) agreements. This rise in subscription-based and leasing deployments suggests that a substantial segment of the automation market is restricting capital spending due to budget constraints, meaning that while the operational need for efficiency remains strong, traditional procurement models continue to limit broader adoption among fiscally restricted tiers of the industry.
Market Trends
The incorporation of Artificial Intelligence for Predictive Workflows is transforming laboratory operations by shifting systems from passive execution to proactive optimization. Instead of merely automating repetitive tasks like plate movements or liquid handling, advanced algorithms now assess experimental parameters in real-time to anticipate instrument failures, identify data anomalies, and optimize assay scheduling before workflows conclude. This move toward data-driven, intelligent ecosystems enables facilities to reduce expensive reagent waste and hasten discovery timelines; according to the Pistoia Alliance's 'Lab of the Future 2024 Global Survey' from September 2024, 68% of life science professionals now utilize Artificial Intelligence and Machine Learning, reflecting a significant year-over-year increase as labs prioritize data readiness.
Concurrently, the expansion of automated solutions into Next-Generation Sequencing and genomics is stimulating significant market activity as laboratories tackle the complex demands of precision medicine. Automating these sensitive genomic workflows necessitates robots with extreme precision to handle micro-volumes of costly biological samples and prevent cross-contamination, a requirement traditional industrial automation could not fulfill. This has led to a surge in orders for specialized biomedical robotic systems, a trend highlighted by the Association for Advancing Automation in February 2025; their report noted that robot orders from the pharmaceutical, life sciences, and biomedical sectors rose by 46% in 2024, outpacing traditional industrial segments.
Report Scope
In this report, the Global Laboratory Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Laboratory Robotics Market.
Global Laboratory Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: